Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 1, 2012, Pages 273-282

  Tsuda, Takeshi ^a,b   Wu, Jing ^b   Gao, Erhe ^a   Joyce, Jennifer ^b   Markova, Dessislava ^a   Dong, Hailong ^b   Liu, Ying ^b   Zhang, Hangxiang ^b   Zou, Yaqun ^a   Gao, Feng ^a   Miller, Thomas ^b   Koch, Walter ^a   Ma, Xingliang ^a   Chu, Mon Li ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Cardiac remodeling; Coronary artery ligation; Extracellular matrix; Transforming growth factor ; Wound healing

Indexed keywords

ANGIOTENSIN II; FIBULIN; FIBULIN 2; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TROPONIN I; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FIBROBLAST; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART PROTECTION; HEART RUPTURE; HEART VENTRICLE FAILURE; HEART VENTRICLE REMODELING; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SURVIVAL; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; WOUND HEALING;

MUS;

EID: 84155188811     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.11.001     Document Type: Article

References (34)

1. Ertl G., Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005, 66:22-32.
2. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation 2003, 108:1395-1403.
3. Dobaczewski M., Gonzalez-Quesada C., Frangogiannis N.G. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 2010, 48:504-511.
4. Timpl R., Sasaki T., Kostka G., Chu M.L. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003, 4:479-489.
5. Tsuda T., Wang H., Timpl R., Chu M.L. Fibulin-2 expression marks transformed mesenchymal cells in developing cardiac valves, aortic arch vessels, and coronary vessels. Dev Dyn 2001, 222:89-100.
6. Fassler R., Sasaki T., Timpl R., Chu M.L., Werner S. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp Cell Res 1996, 222:111-116.
7. Strom A., Olin A.I., Aspberg A., Hultgardh-Nilsson A. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res 2006, 69:755-763.
8. Sicot F.X., Tsuda T., Markova D., Klement J.F., Arita M., Zhang R.Z., et al. Fibulin-2 is dispensable for mouse development and elastic fiber formation. Mol Cell Biol 2008, 28:1061-1067.
9. Tsuda T., Gao E., Evangelisti L., Markova D., Ma X., Chu M.L. Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc Res 2003, 59:926-933.
10. Pan T.C., Sasaki T., Zhang R.Z., Fassler R., Timpl R., Chu M.L. Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding. J Cell Biol 1993, 123:1269-1277.
11. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., et al. Genes expressed in human tumor endothelium. Science 2000, 289:1197-1202.
12. Miller T.L., Shashikant B.N., Pilon A.L., Pierce R.A., Shaffer T.H., Wolfson M.R. Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distress. Pediatr Crit Care Med 2007, 8:40-46.
13. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007, 74:184-195.
14. Roy S., Khanna S., Rink C., Biswas S., Sen C.K. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics 2008, 34:162-184.
15. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 1999, 11:634-640.
16. Cleutjens J.P., Blankesteijn W.M., Daemen M.J., Smits J.F. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 1999, 44:232-241.
17. Cleutjens J.P., Creemers E.E. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction. J Card Fail 2002, 8:S344-S348.
18. Schellings M.W., Pinto Y.M., Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 2004, 64:24-31.
19. Bujak M., Ren G., Kweon H.J., Dobaczewski M., Reddy A., Taffet G., et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007, 116:2127-2138.
20. Hayashidani S., Tsutsui H., Ikeuchi M., Shiomi T., Matsusaka H., Kubota T., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 2003, 285:H1229-H1235.
21. Bergman M.R., Teerlink J.R., Mahimkar R., Li L., Zhu B.Q., Nguyen A., et al. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol 2007, 292:H1847-H1860.
22. Zhang D., Gaussin V., Taffet G.E., Belaguli N.S., Yamada M., Schwartz R.J., et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 2000, 6:556-563.
23. Harada K., Sugaya T., Murakami K., Yazaki Y., Komuro I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 1999, 100:2093-2099.
24. Lijnen P.J., Petrov V.V., Fagard R.H. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 2000, 71:418-435.
25. Sasaki T., Gohring W., Pan T.C., Chu M.L., Timpl R. Binding of mouse and human fibulin-2 to extracellular matrix ligands. J Mol Biol 1995, 254:892-899.
26. Ono R.N., Sengle G., Charbonneau N.L., Carlberg V., Bachinger H.P., Sasaki T., et al. Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. J Biol Chem 2009, 284:16872-16881.
27. Charbonneau N.L., Ono R.N., Corson G.M., Keene D.R., Sakai L.Y. Fine tuning of growth factor signals depends on fibrillin microfibril networks. Birth Defects Res C Embryo Today 2004, 72:37-50.
28. Dallas S.L., Sivakumar P., Jones C.J., Chen Q., Peters D.M., Mosher D.F., et al. Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J Biol Chem 2005, 280:18871-18880.
29. Ji Y., Prasad N.B., Novotny E.A., Kaur S., Elkahloun A., Chen Y., et al. Mouse embryo fibroblasts lacking the tumor suppressor menin show altered expression of extracellular matrix protein genes. Mol Cancer Res 2007, 5:1041-1051.
30. Oka T., Xu J., Kaiser R.A., Melendez J., Hambleton M., Sargent M.A., et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007, 101:313-321.
31. Westermann D., Mersmann J., Melchior A., Freudenberger T., Petrik C., Schaefer L., et al. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 2008, 117:1269-1276.
32. Schellings M.W., Vanhoutte D., Swinnen M., Cleutjens J.P., Debets J., van Leeuwen R.E., et al. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 2009, 206:113-123.
33. Norris R.A., Damon B., Mironov V., Kasyanov V., Ramamurthi A., Moreno-Rodriguez R., et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007, 101:695-711.
34. Young M.F., Bi Y., Ameye L., Chen X.D. Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 2002, 19:257-262.